Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - SYNAGEVA BIOPHARMA CORPFinancial_Report.xls
EX-31.2 - CERTIFICATION BY JAMES R. THOMAS AS CHIEF FINANCIAL OFFICER - SYNAGEVA BIOPHARMA CORPdex312.htm
EX-32.1 - CERTIFICATION BY MARTIN A. MATTINGLY AS CHIEF EXECUTIVE OFFICER - SYNAGEVA BIOPHARMA CORPdex321.htm
EX-31.1 - CERTIFICATION BY MARTIN A. MATTINGLY AS CHIEF EXECUTIVE OFFICER - SYNAGEVA BIOPHARMA CORPdex311.htm
10-Q - FORM 10-Q - SYNAGEVA BIOPHARMA CORPd10q.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Trimeris, Inc. (the “Company”) for the quarterly period ended June 30, 2011 as filed with Securities and Exchange Commission on the date hereof (the “Report”), I, James R. Thomas, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/    JAMES R.THOMAS

James R. Thomas

Chief Financial Officer

and Secretary

August 12, 2011

The foregoing certification is being furnished solely pursuant to 18 U.S.C. § 1350 and is not being filed as part of the Report or as a separate disclosure document.

A signed original of this written statement required by § 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.